Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Abstract Background Interleukin-11 (IL-11), a dominant IL-6 family cytokine, is involved in tumorigenesis, tumor progression and differentiation in colon cancer cells. IL-11 signaling has been recently identified as a potential therapeutic target in colon cancer. Bazedoxifene, a third- generation se...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2019-02-01
|
| Edice: | Journal of Experimental & Clinical Cancer Research |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s13046-019-1072-8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|